Accurate diagnosis of tumorcharacteristics, including its location andb oundary,i so fi mmense value to subsequent therapy. Activatable magnetic resonance imaging (MRI) contrasta gents that respond to tumor-specific microenvironments, such as the redox state, pH, and enzymea ctivity,e nable better mapping of tumor tissue. However,t he practical application of most reported activatable agents is hampered by problems including potential toxicity,i nefficient elimination, and slow activation. In this study,w ed eveloped az witterionic iron complex (Fe-ZDS) as ap ositive MRI contrast agent for tumor-specific imaging. Fe-ZDS could dissociate in weakly acidic solutionr apidly, accompanied by clear longitudinal relaxivity (r 1 )e nhancement, whiche nabled the complex to act as ap H-sensitive contrast agent for tumor-specific MR imaging. In vivo experiments showedt hat Fe-ZDS rapidlye nhanced the tumor-to-normal contrast ratio by > 40 %, which assisted in distinguishing the tumor boundary.F urthermore, Fe-ZDS circulated freely in the bloodstream and was excreted relativelys afely via kidneys owing to its zwitterionic nature. Therefore, Fe-ZDS is an ideal candidate for at umor-specific MRI contrast agent and holds considerable potentialfor clinical translation.Scheme1.Schematicillustration of the pH-responsiveness of Fe-ZDS and the application of the complex as as mart MRI contrastagent for in vivo tumorimaging.